California National Primate Research Center

Davis, CA, United States

California National Primate Research Center

Davis, CA, United States
SEARCH FILTERS
Time filter
Source Type

News Article | May 3, 2017
Site: www.futurity.org

A new study shows that gene editing using CRISPR/Cas9 technology can work in rhesus monkey embryos. The results, published in the current issue of Human Molecular Genetics, open the door for pursuing gene editing in nonhuman primates as models for new therapies, including pharmacological, gene-, and stem cell-based therapies, says Keith Latham, animal science professor at Michigan State University and lead author of the study. “Our paper is the first in the US to publish on the use of this technology in nonhuman primate embryos,” he says. “Using nonhuman primate embryos is important because the closer we can approximate the human condition in the animal model, the better the chances of developing successful treatments as well as limiting risks that may be encountered in clinical trials.” While mice are mammals, they bear litters rather than individual offspring. Their anatomy and physiology differ in many respects from humans. While many advances in understanding diseases have been made first using mouse models, making the leap from a successful mouse study to clinical trials can be difficult or impossible for some areas of research. “If scientists want to test drugs for dementia, Alzheimer’s, or autism, ideal models would react similarly to humans in regards to the reduction of symptoms, outbreak of side effects, such as enduring the same lesions as humans do, or exhibiting similar behavioral characteristics,” says Latham. “Nonhuman primates are much better models for such diseases. And in terms of some surgical procedures, implants, developing prosthetics, or other therapies, nonhuman primates can prove better suited than rodents.” CRISPR has opened the door to do gene editing in many species other than mice. Developing this technology in nonhuman primates in the US would allow more scientists in this country to incorporate these models into their research, he adds. The advances will allow scientists to move forward and tackle some of the technical barriers related to the research. Other issues that may be later resolved are the commitment to increased costs and longer waiting times when using nonhuman primates. Fruit flies, often used in genetic studies, reproduce in two weeks. Rodents, with pre-disposed genetic characteristics, can be easily ordered and shipped to laboratories within days. Committing to raising nonhuman primates can cost around $15,000 and can take as long as four-to-six years to have a mature monkey with the desired genetic characteristics. The high-efficiency of gene editing that scientists are now able to achieve makes it worth the cost and the wait, Latham says. To conduct the research, Latham worked with the California National Primate Research Center, where the monkey embryos were produced, in collaboration with his co-investigator Catherine VandeVoort, an expert in nonhuman primate reproduction. Daniel Bauer, at Harvard Medical School, Boston Children’s Hospital, and Dana-Farber Cancer Institute also collaborated on the study. “Extreme amounts of care go into maintaining the well-being of the monkeys,” says Latham. “They follow strict protocols to ensure this is a priority. Funding came from the National Institutes of Health, Michigan State’s AgBioResearch, Michigan State, the National Institute of Diabetes and Digestive and Kidney Disease, the Burroughs Wellcome Fund, American Society of Hematology, Charles H. Hood Foundation, and Cooley’s Anemia Foundation.


News Article | May 1, 2017
Site: www.eurekalert.org

EAST LANSING, Mich. - Mice have been and will continue to be good base models for human medicinal advances. However, their size and some of their physiological differences leave them lacking in important areas of human medicine, including neurological and reproductive research. In a study led by Michigan State University, scientists have shown that gene editing using CRISPR/Cas9 technology can be quite effective in rhesus monkey embryos ¬- the first time this has been demonstrated in the U.S. The results, published in the current issue of Human Molecular Genetics, open the door for pursuing gene editing in nonhuman primates as models for new therapies, including pharmacological, gene- and stem cell-based therapies, said Keith Latham, MSU animal science professor and lead author of the study. "Our paper is the first in the U.S. to publish on the use of this technology in nonhuman primate embryos," he said. "Using nonhuman primate embryos is important because the closer we can approximate the human condition in the animal model, the better the chances of developing successful treatments as well as limiting risks that may be encountered in clinical trials." While mice are mammals, they bear litters rather than individual offspring. Their anatomy and physiology differ in many respects from humans. While many advances in understanding diseases have been made first using mouse models, making the leap from a successful mouse study to clinical trials can be difficult or impossible for some areas of research. "If scientists want to test drugs for dementia, Alzheimer's or autism, ideal models would react similarly to humans in regards to the reduction of symptoms, outbreak of side effects, such as enduring the same lesions as humans do, or exhibiting similar behavioral characteristics," said Latham, who's with the College of Agriculture and Natural Resources and an MSU AgBioResearch scientist. "Nonhuman primates are much better models for such diseases. And in terms of some surgical procedures, implants, developing prosthetics, or other therapies, nonhuman primates can prove better suited than rodents." CRISPR has opened the door to do gene editing in many species other than mice. Developing this technology in nonhuman primates in the U.S. would allow more scientists in this country to incorporate these models into their research, he added. The advances will allow scientists to move forward and tackle some of the technical barriers related to the research. Other issues that may be later resolved are the commitment to increased costs and longer waiting times when using nonhuman primates. Fruit flies, often used in genetic studies, reproduce in two weeks. Rodents, with pre-disposed genetic characteristics, can be easily ordered and shipped to laboratories within days. Committing to raising nonhuman primates can cost around $15,000 and can take as long as 4-6 years to have a mature monkey with the desired genetic characteristics. The high-efficiency of gene editing that scientists are now able to achieve makes it worth the cost and the wait, Latham said. To conduct the research, Latham partnered with the California National Primate Research Center, where the monkey embryos were produced, in collaboration with his co-investigator Dr. Catherine VandeVoort, an expert in nonhuman primate reproduction. Dr. Daniel Bauer, at Harvard Medical School, Boston Children's Hospital and Dana-Farber Cancer Institute also collaborated on the study. The resources offered by the CNPRC were crucial for this work, Latham said. "Extreme amounts of care go into maintaining the well-being of the monkeys," he said. "They follow strict protocols to ensure this is a priority. So being able to conduct the science here at Michigan State while partnering with the center is the best combination of science and animal welfare." Additional MSU scientists contributing to the study include Uros Midic, Kailey Vincent and Benjamin Goheen. This research was funded by the National Institutes of Health, MSU AgBioResearch, MSU, the National Institute of Diabetes and Digestive and Kidney Disease, the Burroughs Wellcome Fund, American Society of Hematology, Charles H. Hood Foundation and Cooley's Anemia Foundation. Michigan State University has been working to advance the common good in uncommon ways for more than 150 years. One of the top research universities in the world, MSU focuses its vast resources on creating solutions to some of the world's most pressing challenges, while providing life-changing opportunities to a diverse and inclusive academic community through more than 200 programs of study in 17 degree-granting colleges. For MSU news on the Web, go to MSUToday. Follow MSU News on Twitter at twitter.com/MSUnews.


News Article | May 1, 2017
Site: www.chromatographytechniques.com

Mice have been and will continue to be good base models for human medicinal advances. However, their size and some of their physiological differences leave them lacking in important areas of human medicine, including neurological and reproductive research. In a study led by Michigan State University, scientists have shown that gene editing using CRISPR/Cas9 technology can be quite effective in rhesus monkey embryos ­– the first time this has been demonstrated in the U.S. The results, published in the current issue of Human Molecular Genetics, open the door for pursuing gene editing in nonhuman primates as models for new therapies, including pharmacological, gene- and stem cell-based therapies, said Keith Latham, MSU animal science professor and lead author of the study. “Our paper is the first in the U.S. to publish on the use of this technology in nonhuman primate embryos,” he said. “Using nonhuman primate embryos is important because the closer we can approximate the human condition in the animal model, the better the chances of developing successful treatments as well as limiting risks that may be encountered in clinical trials.” While mice are mammals, they bear litters rather than individual offspring. Their anatomy and physiology differ in many respects from humans. While many advances in understanding diseases have been made first using mouse models, making the leap from a successful mouse study to clinical trials can be difficult or impossible for some areas of research. “If scientists want to test drugs for dementia, Alzheimer’s or autism, ideal models would react similarly to humans in regards to the reduction of symptoms, outbreak of side effects, such as enduring the same lesions as humans do, or exhibiting similar behavioral characteristics,” said Latham, who’s with the College of Agriculture and Natural Resources and an MSU AgBioResearch scientist. “Nonhuman primates are much better models for such diseases. And in terms of some surgical procedures, implants, developing prosthetics, or other therapies, nonhuman primates can prove better suited than rodents.” CRISPR has opened the door to do gene editing in many species other than mice. Developing this technology in nonhuman primates in the U.S. would allow more scientists in this country to incorporate these models into their research, he added. The advances will allow scientists to move forward and tackle some of the technical barriers related to the research. Other issues that may be later resolved are the commitment to increased costs and longer waiting times when using nonhuman primates. Fruit flies, often used in genetic studies, reproduce in two weeks. Rodents, with pre-disposed genetic characteristics, can be easily ordered and shipped to laboratories within days. Committing to raising nonhuman primates can cost around $15,000 and can take as long as four to six years to have a mature monkey with the desired genetic characteristics. The high-efficiency of gene editing that scientists are now able to achieve makes it worth the cost and the wait, Latham said. To conduct the research, Latham partnered with the California National Primate Research Center, where the monkey embryos were produced, in collaboration with his co-investigator Catherine VandeVoort, an expert in nonhuman primate reproduction. Daniel Bauer, at Harvard Medical School, Boston Children’s Hospital and Dana-Farber Cancer Institute also collaborated on the study. The resources offered by the CNPRC were crucial for this work, Latham said. “Extreme amounts of care go into maintaining the well-being of the monkeys,” he said. “They follow strict protocols to ensure this is a priority. So being able to conduct the science here at Michigan State while partnering with the center is the best combination of science and animal welfare.”


Bales K.L.,University of California at Davis | Bales K.L.,California National Primate Research Center | Perkeybile A.M.,University of California at Davis | Conley O.G.,University of California at Davis | And 7 more authors.
Biological Psychiatry | Year: 2013

Background: Oxytocin (OT) is a hormone shown to be involved in social bonding in animal models. Intranasal OT is currently in clinical trials for use in disorders such as autism and schizophrenia. We examined long-term effects of intranasal OT given developmentally in the prairie vole (Microtus ochrogaster), a socially monogamous rodent, often used as an animal model to screen drugs that have therapeutic potential for social disorders. Methods: We treated voles with one of three dosages of intranasal OT, or saline, from day 21 (weaning) through day 42 (sexual maturity). We examined both social behavior immediately following administration, as well as long-term changes in social and anxiety behavior after treatment ceased. Group sizes varied from 8 to 15 voles (n = 89 voles total). Results: Treatment with OT resulted in acute increases in social behavior in male voles with familiar partners, as seen in humans. However, long-term developmental treatment with low doses of intranasal OT resulted in a deficit in partner preference behavior (a reduction of contact with a familiar opposite-sex partner, used to index pair-bond formation) by male voles. Conclusions: Long-term developmental treatment with OT may show results different to those predicted by short-term studies, as well as significant sex differences and dosage effects. Further animal study is crucial to determining safe and effective strategies for use of chronic intranasal OT, especially during development. © 2013 Society of Biological Psychiatry.


Ragen B.J.,University of California at Davis | Ragen B.J.,California National Primate Research Center | Maninger N.,California National Primate Research Center | Mendoza S.P.,California National Primate Research Center | And 2 more authors.
Neuroscience | Year: 2015

The μ opioid receptor (MOR) and κ opioid receptor (KOR) have been implicated in pair-bond formation and maintenance in socially monogamous species. Utilizing monogamous titi monkeys (. Callicebus cupreus), the present study examined the potential role opioids play in modulating the response to separation, a potent challenge to the pair-bond. In Experiment 1, paired male titi monkeys were separated from their pair-mate for 30-min and then received saline, naloxone (1.0. mg/kg), morphine (0.25. mg/kg), or the KOR agonist, U50,488 (0.01, 0.03, or 0.1. mg/kg) in a counter-balanced fashion, immediately prior to a 30-min reunion with their mate. Blood samples were collected immediately prior to and after the reunion. Males receiving morphine approached females less, initiated contact less, and females broke contact with the males less. The increase in cortisol in response to naloxone was greater compared to vehicle, and the increase in cortisol in response to the high dose of U50,488 compared to vehicle approached significance. In Experiment 2, paired males were treated with the KOR antagonist, GNTI (0.1, 0.3, or 1.0. mg/kg), or saline 24. h prior to a 60-min separation from their mate. Blood samples were collected at the time of injection and immediately before and after separation. Administration of the low dose of GNTI decreased the locomotor component of the separation response compared to vehicle. The present study found that the opioid system is involved in both the affiliative and separation distress components of a pair-bond, and these components are regulated by different opioid receptors. © 2014 IBRO.


Broadhurst M.J.,University of California at San Francisco | Ardeshir A.,California National Primate Research Center | Kanwar B.,University of California at San Francisco | Mirpuri J.,University of Texas Southwestern Medical Center | And 9 more authors.
PLoS Pathogens | Year: 2012

Idiopathic chronic diarrhea (ICD) is a leading cause of morbidity amongst rhesus monkeys kept in captivity. Here, we show that exposure of affected animals to the whipworm Trichuris trichiura led to clinical improvement in fecal consistency, accompanied by weight gain, in four out of the five treated monkeys. By flow cytometry analysis of pinch biopsies collected during colonoscopies before and after treatment, we found an induction of a mucosal TH2 response following helminth treatment that was associated with a decrease in activated CD4+ Ki67+ cells. In parallel, expression profiling with oligonucleotide microarrays and real-time PCR analysis revealed reductions in TH1-type inflammatory gene expression and increased expression of genes associated with IgE signaling, mast cell activation, eosinophil recruitment, alternative activation of macrophages, and worm expulsion. By quantifying bacterial 16S rRNA in pinch biopsies using real-time PCR analysis, we found reduced bacterial attachment to the intestinal mucosa post-treatment. Finally, deep sequencing of bacterial 16S rRNA revealed changes to the composition of microbial communities attached to the intestinal mucosa following helminth treatment. Thus, the genus Streptophyta of the phylum Cyanobacteria was vastly increased in abundance in three out of five ICD monkeys relative to healthy controls, but was reduced to control levels post-treatment; by contrast, the phylum Tenericutes was expanded post-treatment. These findings suggest that helminth treatment in primates can ameliorate colitis by restoring mucosal barrier functions and reducing overall bacterial attachment, and also by altering the communities of attached bacteria. These results also define ICD in monkeys as a tractable preclinical model for ulcerative colitis in which these effects can be further investigated. © 2012 Broadhurst et al.


Maninger N.,University of California at San Francisco | Maninger N.,California National Primate Research Center | Capitanio J.P.,California National Primate Research Center | Mason W.A.,California National Primate Research Center | And 2 more authors.
Psychoneuroendocrinology | Year: 2010

Most studies on the stress-responsiveness of the hypothalamic-pituitary-adrenal (HPA) axis have focused on glucocorticoids, while few studies have investigated the adrenal secretion of dehydroepiandrosterone sulfate (DHEAS), which is unique to primates. Monkeys were chair-restrained for 2. h per day for seven consecutive days, and blood samples were collected upon placement in the chair, and at 15, 30, 60 and 120. min later. Like cortisol, DHEAS concentrations increased throughout the initial session of chair restraint (acute stress). Unlike the cortisol response, which decreased after repeated exposure to the stressor, the DHEAS response was sustained throughout the seventh session of restraint (chronic stress) and response to the seventh session of restraint did not differ from the DHEAS response to the initial session. Like cortisol, DHEAS concentrations showed a diurnal rhythm with higher concentrations in the morning compared to the evening and a decrease in response to dexamethasone (DEX) administration. After repeated exposure to the stressor, the suppression of DHEAS in response to dexamethasone was more complete, suggesting an increase in negative feedback sensitivity. These data show that DHEAS concentrations increase in response to both acute and chronic (repeated) stress and provide another measure of HPA activity that parallels cortisol during acute responses to stress but diverges in chronic or repeated stress. © 2010.


Machado C.J.,University of California | Machado C.J.,California National Primate Research Center | Whitaker A.M.,University of California | Whitaker A.M.,California National Primate Research Center | And 4 more authors.
Biological Psychiatry | Year: 2015

Background Sickness during pregnancy is associated with an increased risk of offspring neurodevelopmental disorders. Rodent models have played a critical role in establishing causal relationships and identifying mechanisms of altered brain and behavior development in pups prenatally exposed to maternal immune activation (MIA). We recently developed a novel nonhuman primate model to bridge the gap between human epidemiological studies and rodent models of prenatal immune challenge. Our initial results demonstrated that rhesus monkeys given the viral mimic synthetic double-stranded RNA (polyinosinic:polycytidylic acid stabilized with poly-l-lysine) during pregnancy produce offspring with abnormal repetitive behaviors, altered communication, and atypical social interactions. Methods We utilized noninvasive infrared eye tracking to further evaluate social processing capabilities in a subset of the first trimester MIA-exposed offspring (n = 4) and control animals (n = 4) from our previous study. Results As juveniles, the MIA offspring differed from control animals on several measures of social attention, particularly when viewing macaque faces depicting the fear grimace facial expression. Compared with control animals, MIA offspring had a longer latency before fixating on the eyes, had fewer fixations directed at the eyes, and spent less total time fixating on the eyes of the fear grimace images. Conclusions In the rhesus monkey model, exposure to MIA at the end of the first trimester results in abnormal gaze patterns to salient social information. The use of noninvasive eye tracking extends the findings from rodent MIA models to more human-like behaviors resembling those in both autism spectrum disorder and schizophrenia. © 2015 Society of Biological Psychiatry.


Bales K.L.,University of California at Davis | Bales K.L.,California National Primate Research Center | Saltzman W.,University of California at Riverside
Hormones and Behavior | Year: 2016

This article is part of a Special Issue "Parental Care". Paternal care, though rare among mammals, is routinely displayed by several species of rodents. Here we review the neuroanatomical and hormonal bases of paternal behavior, as well as the behavioral and neuroendocrine consequences of paternal behavior for offspring. Fathering behavior is subserved by many of the same neural substrates which are also involved in maternal behavior (for example, the medial preoptic area of the hypothalamus). While gonadal hormones such as testosterone, estrogen, and progesterone, as well as hypothalamic neuropeptides such as oxytocin and vasopressin, and the pituitary hormone prolactin, are implicated in the activation of paternal behavior, there are significant gaps in our knowledge of their actions, as well as pronounced differences between species. Removal of the father in biparental species has long-lasting effects on behavior, as well as on these same neuroendocrine systems, in offspring. Finally, individual differences in paternal behavior can have similarly long-lasting, if more subtle, effects on offspring behavior. Future studies should examine similar outcome measures in multiple species, including both biparental species and closely related uniparental species. Careful phylogenetic analyses of the neuroendocrine systems presumably important to male parenting, as well as their patterns of gene expression, will also be important in establishing the next generation of hypotheses regarding the regulation of male parenting behavior. © 2015 Elsevier Inc.


The male contraceptive gel Vasalgel was shown effective in preventing pregnancies in trials conducted on a group of rhesus monkeys. Results of the trial, which was published in Basic and Clinical Andrology on Feb. 7, showed that despite typically high pregnancy rates of about 80 percent in female monkeys housed with males, no pregnancy occurred over the study period covering at least one breeding season when the males were treated with the contraceptive gel. The findings offer hope for a new birth control method that men can use. If proven effective and safe enough for humans, Vasalgel could be an alternative for vasectomy. "One of the great things about the monkey model is that the male reproductive tract is very similar to humans and they have even more sperm than humans do," said Catherine VandeVoort, from the California National Primate Research Center. "Chances are, it's going to be effective in humans." Withdrawal method and condoms are currently the best option for these men but withdrawal method poses high pregnancy risk and condoms can disrupt spontaneity during sexual contact. Although vasectomy is highly effective, it is poorly reversible, which means it is not the best option for those who need temporary protection. Based on earlier trials involving rabbits, Vasalgel could be a sort of a reversible vasectomy albeit results of animal studies still need to be replicated in humans. While other studies are also being conducted to develop a male hormonal contraceptive that can be as effective as the birth control pills taken by women, scientists are concerned over the unwanted side effects of these types treatment which include depression and soaring libido. The Vasalgel though does not interfere with the production of sperm nor changes the hormone levels in the body, which means that the side effects seen in hormone-altering pills, gels, and injections would not be an issue. While VandeVoort and colleagues reported that use of Vasalgel was well tolerated in monkey subjects, there are still issues and complications that arose due to use of the contraceptive gel. The researchers, for instance, inserted the gel into one of the 16 monkeys involved in the trial incorrectly. "Complications during Vasalgel placement in one animal (Animal 3) were associated with damage to the wall of the vas deferens, likely as a result of incorrect placement of the catheter, resulting in incomplete penetration of the wall of the vas deferens," the study researchers wrote in their study. "This resulted in extraluminal leakage of Vasalgel within the thin fibrous sheath surrounding the vas, likely weakening the overall structure." Another subject also developed sperm granuloma. The condition, which is caused by leaking sperm, is characterized by a lump of sperm forming at the site where the vas deferens, the tube that carries the sperm from the testes to the penis, is tied off. Granuloma commonly occurs after vasectomy. Inflammation, which also commonly occurs after vasectomy, however, was minimal with Vasalgel. © 2017 Tech Times, All rights reserved. Do not reproduce without permission.

Loading California National Primate Research Center collaborators
Loading California National Primate Research Center collaborators